propranolol has been researched along with Abdominal Aortic Aneurysm in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated whether propranolol decreases the growth rate of small abdominal aortic aneurysms (AAAs)." | 9.10 | Propranolol for small abdominal aortic aneurysms: results of a randomized trial. ( , 2002) |
| "To study the propranolol treatment of small abdominal aortic aneurysms (AAA) concerning intention to treat, side effects, and inhibition of expansion." | 9.09 | Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. ( Fasting, H; Henneberg, EW; Juul, S; Lindholt, JS, 1999) |
| "Propranolol has been suggested to slow aortic aneurysm (AAA) expansion by a mechanism independent of simple blood pressure (BP) reduction." | 5.29 | Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model. ( Gadowski, GR; Hendley, ED; Nichols, P; Pilcher, DB; Ricci, MA; Slaiby, JM, 1996) |
| " We investigated whether propranolol decreases the growth rate of small abdominal aortic aneurysms (AAAs)." | 5.10 | Propranolol for small abdominal aortic aneurysms: results of a randomized trial. ( , 2002) |
| "To study the propranolol treatment of small abdominal aortic aneurysms (AAA) concerning intention to treat, side effects, and inhibition of expansion." | 5.09 | Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. ( Fasting, H; Henneberg, EW; Juul, S; Lindholt, JS, 1999) |
| " Using a mail survey, we elicited the MID of different physician specialties (family medicine, internal medicine, vascular surgery) for using propranolol to slow abdominal aortic aneurysm (AAA) growth assuming that propranolol was efficacious in this condition." | 3.70 | Surveying physicians to determine the minimal important difference: implications for sample-size calculation. ( Bohm, C; Laupacis, A; Mahon, JL; Moher, D; van Walraven, C, 1999) |
| "Propranolol was poorly tolerated by patients in all of the beta-blocker trials and demonstrated only minimal and non-significant protective effects." | 2.48 | Medical treatment for small abdominal aortic aneurysms. ( Clarke, M; Robertson, L; Rughani, G, 2012) |
| "Abdominal aortic aneurysm is a common condition that may be lethal when it is unrecognized." | 2.44 | Medical management of small abdominal aortic aneurysms. ( Baxter, BT; Dalman, RL; Terrin, MC, 2008) |
| "A propranolol dose-response was studied for each strain: (1) saline solution controls (n = 18); (2) propranolol, 10 mg/kg subcutaneously (n = 18); (3) propranolol, 30 mg/kg (n = 14)." | 1.29 | Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model. ( Gadowski, GR; Hendley, ED; Pilcher, DB; Ricci, MA; Slaiby, JM, 1994) |
| "Propranolol has been suggested to slow aortic aneurysm (AAA) expansion by a mechanism independent of simple blood pressure (BP) reduction." | 1.29 | Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model. ( Gadowski, GR; Hendley, ED; Nichols, P; Pilcher, DB; Ricci, MA; Slaiby, JM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assar, AN | 1 |
| Rughani, G | 1 |
| Robertson, L | 1 |
| Clarke, M | 1 |
| Baxter, BT | 1 |
| Terrin, MC | 1 |
| Dalman, RL | 1 |
| Slaiby, JM | 2 |
| Ricci, MA | 3 |
| Gadowski, GR | 2 |
| Hendley, ED | 2 |
| Pilcher, DB | 3 |
| Mellière, D | 1 |
| Cronenwett, JL | 1 |
| Nichols, P | 1 |
| McBride, R | 1 |
| Lindholt, JS | 1 |
| Henneberg, EW | 1 |
| Juul, S | 1 |
| Fasting, H | 1 |
| van Walraven, C | 1 |
| Mahon, JL | 1 |
| Moher, D | 1 |
| Bohm, C | 1 |
| Laupacis, A | 1 |
5 reviews available for propranolol and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Medical treatment of small abdominal aortic aneurysm.
Topics: Aortic Aneurysm, Abdominal; Cardiovascular Agents; Disease Progression; Doxycycline; Humans; Hydroxy | 2012 |
Medical treatment for small abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Azithromycin; Doxycy | 2012 |
Medical management of small abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2008 |
[Asymptomatic aneurysms of the abdominal aorta: in whom are they detected? When should a beta-blocker be prescribed? Who should have surgery and by which technique?].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aneurysm, Ruptured; Aortic Aneurysm, Abdominal | 1995 |
Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Comorbidity; Diastole; Dise | 1996 |
3 trials available for propranolol and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Design of a trial to evaluate the effect of propranolol upon abdominal aortic aneurysm expansion.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Disease Progression; Double | 1996 |
Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Aged; Aortic Aneurysm, Abdominal; Double-Blind Method; Dyspnea; Humans; | 1999 |
Propranolol for small abdominal aortic aneurysms: results of a randomized trial.
Topics: Adrenergic beta-Antagonists; Aged; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Double-Blind Method | 2002 |
3 other studies available for propranolol and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model.
Topics: Analysis of Variance; Animals; Aortic Aneurysm, Abdominal; Dose-Response Relationship, Drug; Female; | 1994 |
Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model.
Topics: Adrenergic beta-Antagonists; Aged; Animals; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Aor | 1996 |
Surveying physicians to determine the minimal important difference: implications for sample-size calculation.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Attitude of Health Personnel; Data Collecti | 1999 |